Selective intra-arterial mitomycin-C infusions for treatment-refractory colorectal liver metastases
In this heavily pretreated population, addition of intra-arterial mitomycin-C was associated with initial liver disease control rates exceeding 80%. Toxicities were observed, particularly in patients with prolonged disease control who received ≥4 infusions.
Authors
- Erica S. Alexander (ORCID: https://orcid.org/0000-0001-7880-3565)
- Louise C. Connell (ORCID: https://orcid.org/0000-0002-3193-4629)
- Henry Kunin (ORCID: https://orcid.org/0000-0002-4056-0219)
- Juan C. Camacho (ORCID: https://orcid.org/0000-0002-4593-3723)
- Emma M. Schatoff (ORCID: https://orcid.org/0000-0002-7327-1843)
- Nancy E. Kemeny (ORCID: https://orcid.org/0000-0002-0929-9542)
- Vlasios S. Sotirchos (ORCID: https://orcid.org/0000-0001-7278-1369)
- Constantinos T. Sofocleous (ORCID: https://orcid.org/0000-0002-3142-1399)
- Ken Zhao
- Mikhail Silk
Institutions
- Memorial Sloan Kettering Cancer Center (US)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/jgo-24-725
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64